237 related articles for article (PubMed ID: 12648972)
1. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.
Iizuka N; Oka M; Yamada-Okabe H; Nishida M; Maeda Y; Mori N; Takao T; Tamesa T; Tangoku A; Tabuchi H; Hamada K; Nakayama H; Ishitsuka H; Miyamoto T; Hirabayashi A; Uchimura S; Hamamoto Y
Lancet; 2003 Mar; 361(9361):923-9. PubMed ID: 12648972
[TBL] [Abstract][Full Text] [Related]
2. Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
Yoshioka S; Takemasa I; Nagano H; Kittaka N; Noda T; Wada H; Kobayashi S; Marubashi S; Takeda Y; Umeshita K; Dono K; Matsubara K; Monden M
Eur J Cancer; 2009 Mar; 45(5):881-9. PubMed ID: 19167881
[TBL] [Abstract][Full Text] [Related]
3. A three-gene predictor for early intrahepatic recurrence of hepatocellular carcinoma after curative hepatectomy.
Somura H; Iizuka N; Tamesa T; Sakamoto K; Hamaguchi T; Tsunedomi R; Yamada-Okabe H; Sawamura M; Eramoto M; Miyamoto T; Hamamoto Y; Oka M
Oncol Rep; 2008 Feb; 19(2):489-95. PubMed ID: 18202799
[TBL] [Abstract][Full Text] [Related]
4. Tumor HLA-DR expression linked to early intrahepatic recurrence of hepatocellular carcinoma.
Matoba K; Iizuka N; Gondo T; Ishihara T; Yamada-Okabe H; Tamesa T; Takemoto N; Hashimoto K; Sakamoto K; Miyamoto T; Uchimura S; Hamamoto Y; Oka M
Int J Cancer; 2005 Jun; 115(2):231-40. PubMed ID: 15688398
[TBL] [Abstract][Full Text] [Related]
5. Molecular-based prediction of early recurrence in hepatocellular carcinoma.
Kurokawa Y; Matoba R; Takemasa I; Nagano H; Dono K; Nakamori S; Umeshita K; Sakon M; Ueno N; Oba S; Ishii S; Kato K; Monden M
J Hepatol; 2004 Aug; 41(2):284-91. PubMed ID: 15288478
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: a prospective, multicenter study.
Tanaka S; Mogushi K; Yasen M; Ban D; Noguchi N; Irie T; Kudo A; Nakamura N; Tanaka H; Yamamoto M; Kokudo N; Takayama T; Kawasaki S; Sakamoto M; Arii S
Hepatology; 2011 Oct; 54(4):1273-81. PubMed ID: 22006857
[TBL] [Abstract][Full Text] [Related]
7. A gene expression profile for vascular invasion can predict the recurrence after resection of hepatocellular carcinoma: a microarray approach.
Ho MC; Lin JJ; Chen CN; Chen CC; Lee H; Yang CY; Ni YH; Chang KJ; Hsu HC; Hsieh FJ; Lee PH
Ann Surg Oncol; 2006 Nov; 13(11):1474-84. PubMed ID: 17009164
[TBL] [Abstract][Full Text] [Related]
8. Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma.
Cheung ST; Leung KL; Ip YC; Chen X; Fong DY; Ng IO; Fan ST; So S
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):551-6. PubMed ID: 15701840
[TBL] [Abstract][Full Text] [Related]
9. Different molecular pathways determining extrahepatic and intrahepatic recurrences of hepatocellular carcinoma.
Iizuka N; Tamesa T; Sakamoto K; Miyamoto T; Hamamoto Y; Oka M
Oncol Rep; 2006 Nov; 16(5):1137-42. PubMed ID: 17016605
[TBL] [Abstract][Full Text] [Related]
10. Four gene intrahepatic metastasis-risk signature predicts hepatocellular carcinoma malignant potential and early recurrence from intrahepatic metastasis.
Nakagawa S; Yamashita YI; Umezaki N; Yamao T; Kaida T; Hiyoshi Y; Mima K; Okabe H; Hayashi H; Imai K; Chikamoto A; Baba H
Surgery; 2021 Apr; 169(4):903-910. PubMed ID: 33160638
[TBL] [Abstract][Full Text] [Related]
11. Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.
Woo HG; Park ES; Cheon JH; Kim JH; Lee JS; Park BJ; Kim W; Park SC; Chung YJ; Kim BG; Yoon JH; Lee HS; Kim CY; Yi NJ; Suh KS; Lee KU; Chu IS; Roskams T; Thorgeirsson SS; Kim YJ
Clin Cancer Res; 2008 Apr; 14(7):2056-64. PubMed ID: 18381945
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissue.
Kim BY; Suh KS; Lee JG; Woo SR; Park IC; Park SH; Han CJ; Kim SB; Jeong SH; Yeom YI; Yang SJ; Kim CM; Cho SJ; Yoo YD; Cho MH; Jang JJ; Choi DW; Lee KH
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S328-38. PubMed ID: 21533656
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis.
Nomoto S; Hishida M; Inokawa Y; Takano N; Kanda M; Nishikawa Y; Fujii T; Koike M; Sugimoto H; Kodera Y
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S443-50. PubMed ID: 24604581
[TBL] [Abstract][Full Text] [Related]
14. Gene expression in fixed tissues and outcome in hepatocellular carcinoma.
Hoshida Y; Villanueva A; Kobayashi M; Peix J; Chiang DY; Camargo A; Gupta S; Moore J; Wrobel MJ; Lerner J; Reich M; Chan JA; Glickman JN; Ikeda K; Hashimoto M; Watanabe G; Daidone MG; Roayaie S; Schwartz M; Thung S; Salvesen HB; Gabriel S; Mazzaferro V; Bruix J; Friedman SL; Kumada H; Llovet JM; Golub TR
N Engl J Med; 2008 Nov; 359(19):1995-2004. PubMed ID: 18923165
[TBL] [Abstract][Full Text] [Related]
15. An in situ molecular signature to predict early recurrence in hepatitis B virus-related hepatocellular carcinoma.
Xu J; Ding T; He Q; Yu XJ; Wu WC; Jia WH; Yun JP; Zhang Y; Shi M; Shao CK; Pan WD; Yin XY; Min J; Zhuang SM; Zheng L
J Hepatol; 2012 Aug; 57(2):313-21. PubMed ID: 22521360
[TBL] [Abstract][Full Text] [Related]
16. Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.
Lim HY; Sohn I; Deng S; Lee J; Jung SH; Mao M; Xu J; Wang K; Shi S; Joh JW; Choi YL; Park CK
Ann Surg Oncol; 2013 Nov; 20(12):3747-53. PubMed ID: 23800896
[TBL] [Abstract][Full Text] [Related]
17. Predicting the prognosis of hepatocellular carcinoma using gene expression.
Chang SH; Suh KS; Yi NJ; Lee KH; Kim BY; Jang JJ
J Surg Res; 2011 Dec; 171(2):524-31. PubMed ID: 20828739
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma.
Niu Q; Tang ZY; Qin LX; Ma ZC; Zhang LH
Hepatogastroenterology; 2003; 50(53):1579-82. PubMed ID: 14571790
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma.
Choi GH; Kim DH; Kang CM; Kim KS; Choi JS; Lee WJ; Kim BR
Ann Surg Oncol; 2008 Feb; 15(2):618-29. PubMed ID: 18004628
[TBL] [Abstract][Full Text] [Related]
20. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
